| |
| |
| Summary and Assessment | |
| |
| |
| |
| The Role of Research in Countering Bioterrorism | |
| |
| |
| |
| The Political Perspective of the Bioterrorism Threat | |
| |
| |
| |
| Update on the Implications of Anthrax Bioterrorism | |
| |
| |
| |
| Framing the Issues | |
| |
| |
| |
| Framing the Debate: Applying the Lessons Learned | |
| |
| |
| |
| Building Capacity to Prevent and Respond to Bioterrorism | |
| |
| |
| |
| Bioterrorism: Communicating an Effective Response | |
| |
| |
| |
| Anthrax | |
| |
| |
| |
| Medical Countermeasures Against the Re-emergence of Smallpox Virus | |
| |
| |
| |
| Tularemia and Plague: Assessing Our Understanding of the Threat | |
| |
| |
| |
| Botulinum Toxin as a Bioweapon | |
| |
| |
| |
| Research Considerations for Better Understanding of Biological Threats | |
| |
| |
| |
| Aerosol Technology and Biological Weapons | |
| |
| |
| |
| Reducing the Risk: Foodborne Pathogen and Toxin Diagnostics | |
| |
| |
| |
| Vaccines for Threatening Agents: Ensuring the Availability of Countermeasures for Bioterrorism | |
| |
| |
| |
| The Department of Defense and the Development and Procurement of Vaccines Against Dangerous Pathogens: A Role in the Military and Civilian Sector? | |
| |
| |
| |
| Applications of Modern Technology to Emerging Infections and Disease Development: A Case Study of Ebola Virus | |
| |
| |
| |
| Meeting the Regulatory and Product Development Challenges for Vaccines and Other Biologies to Address Terrorism | |
| |
| |
| |
| Moving the Vaccine Agenda Forward: Obstacles and Opportunities | |
| |
| |
| |
| Countermeasures to Biological Threats: The Challenges of Drug Development | |
| |
| |
| |
| The FDA and the End of Antibiotics | |
| |
| |
| |
| The Role of Antivirals in Responding to Biological Threats | |
| |
| |
| |
| New Research in Antitoxins | |
| |
| |
| |
| Recombinant Human Antibody: Immediate Immunity from Botulinum Neurotoxin and Other Class A Biothreat Agents | |
| |
| |
| |
| Meeting the Regulatory and Product Development Challenges to Address Terrorism | |
| |
| |
| |
| Regulation and Production of Recombinant Human Antibodies | |
| |
| |
| |
| Lessons Being Learned: The Challenges and Opportunities | |
| |
| |
| |
| The Response Infrastructure: Investigating the Anthrax Attacks | |
| |
| |
| |
| The Centers for Disease Control Bioterrorism Investigation | |
| |
| |
| |
| VA Capability to Enhance the Medical Response to a Domestic Biological Threat | |
| |
| |
| |
| The Progress, Priorities, and Concerns of Public Health Laboratories | |
| |
| |
| |
| The Role of the Centers for Public Health Preparedness | |
| |
| |
| |
| The Role of Coordinated Information Dissemination: The Cascade System in the United Kingdom | |
| |
| |
| |
| State and Local Needs for Responding to Bioterrorism | |
| |
| |
| |
| U.S. Public Health Service Office of Emergency Preparedness | |
| |
| |
| |
| Assessing State and Territorial Health Departments | |
| |
| |
| |
| Countering Bioterrorism Threats: Local Public Health Perspectives | |
| |
| |
| |
| Public Health Priorities for Responding to Bioterrorism | |
| |
| |
| |
| Innovative Surveillance Methods for Monitoring Dangerous Pathogens | |
| |
| |
| |
| The Use of Computational Modeling in Responding to Biological Threats | |
| |
| |
| |
| Diagnostics and Detection Methods: Improving Rapid Response Capabilities | |
| |
| |
| |
| National Security and Openness of Scientific Research | |
| |
| |
| |
| Coordinating the Intelligence, Public Health, and Research Communities | |
| |
| |
| |
| Virtually Assured Detection and Response: Utilizing Science, Technology, and Policy Against Bioterrorism | |
| |
| |
| |
| Research and the Public Health Response | |
| |
| |
| |
| |
| Agenda: Biological Threats and Terrorism: How Prepared Are We? Assessing the Science and Our Response Capabilities | |
| |
| |
| App.: Information Resources | |
| |
| |
| |
| Testimony of Joshua Lederberg, Ph.D. | |
| |
| |
| |
| Summary of the Frist-Kennedy "Bioterrorism Preparedness Act of 2001" | |
| |
| |
| |
| Department of Health and Human Services: Food and Drug Administration [Docket No. 01N-0494] | |
| |
| |
| |
| Veterans Affairs/Department of Defense Contingency | |
| |
| |
| |
| The Model State Emergency Health Powers Act | |
| |
| |
| |
| NACCHO Research Brief: Assessment of Local Bioterrorism and Emergency Preparedness | |
| |
| |
| |
| Statement on Vaccine Development | |
| |
| |
| |
| Testimony of Kenneth I. Shine, M.D. | |
| |
| |
| |
| Glossary and Acronyms | |
| |
| |
| |
| Forum Member, Speaker, and Staff Biographies | |